Dr. Aggarwal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
70 Francis St
Boston, MA 02115Phone+1 617-667-7000
Education & Training
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2019 - 2022
Boston University School of MedicineClass of 2019
Certifications & Licensure
MA State Medical License 2019 - 2026- American Board of Internal Medicine Internal Medicine
Clinical Trials
- ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer Start of enrollment: 2021 Jan 26
Publications & Presentations
PubMed
- Trends in Sudden Cardiac Death Among Adults Aged 25 to 44 Years in the United States: An Analysis of 2 Large US Databases.Marco Zuin, Sanghamitra Mohanty, Rahul Aggarwal, Matteo Bertini, Behnood Bikdeli
Journal of the American Heart Association. 2025-01-07 - The PRECISE trial: How should patients with chest pain be tested?Rahul Aggarwal, Ron Blankstein, Deepak L Bhatt
Cleveland Clinic Journal of Medicine. 2024-11-01 - 2 citationsGeneralizability of the Spectrum of Kidney Risk in the FINEARTS-HF Trial to U.S. Adults With Heart Failure.John W Ostrominski, Rahul Aggarwal, Brian L Claggett, Ian J Kulac, Akshay S Desai
Journal of Cardiac Failure. 2024-09-01
Press Mentions
Empagliflozin Confers Kidney-Protective Benefits After Acute MISeptember 10th, 2024- What You Need to Know About CKM, the Link Between Heart Health, Diabetes and Kidney DiseaseMay 19th, 2024
- Diabetes Often Leads to Heart and Kidney Disease, TooMay 15th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
